An update on laboratory assessment for direct oral anticoagulants (DOACs)

RC Gosselin, DM Adcock… - International journal of …, 2019 - Wiley Online Library
The first direct oral anticoagulant (DOAC) to be approved for clinical use was dabigatran, a
direct thrombin inhibitor, in 2010. Since that time, four additional DOACs, all direct anti‐Xa …

[PDF][PDF] An update on laboratory assessment for direct oral anticoagulants (DOACs)

RC Gosselin, DM Adcock, J Douxfils - researchgate.net
The first direct oral anticoagulant (DOAC) to be approved for clinical use was dabigatran, a
direct thrombin inhibitor, in 2010. Since that time, four additional DOACs, all direct anti-Xa …

An update on laboratory assessment for direct oral anticoagulants (DOACs)

RC Gosselin, DM Adcock… - International Journal of …, 2019 - researchportal.unamur.be
The first direct oral anticoagulant (DOAC) to be approved for clinical use was dabigatran, a
direct thrombin inhibitor, in 2010. Since that time, four additional DOACs, all direct anti-Xa …

[PDF][PDF] An update on laboratory assessment for direct oral anticoagulants (DOACs)

RC Gosselin, DM Adcock, J Douxfils - pure.unamur.be
The first direct oral anticoagulant (DOAC) to be approved for clinical use was dabigatran, a
direct thrombin inhibitor, in 2010. Since that time, four additional DOACs, all direct anti-Xa …

An update on laboratory assessment for direct oral anticoagulants (DOACs)

RC Gosselin, DM Adcock… - International journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
The first direct oral anticoagulant (DOAC) to be approved for clinical use was dabigatran, a
direct thrombin inhibitor, in 2010. Since that time, four additional DOACs, all direct anti-Xa …

An update on laboratory assessment for direct oral anticoagulants (DOACs).

RC Gosselin, DM Adcock, J Douxfils - International Journal of …, 2019 - europepmc.org
The first direct oral anticoagulant (DOAC) to be approved for clinical use was dabigatran, a
direct thrombin inhibitor, in 2010. Since that time, four additional DOACs, all direct anti-Xa …